Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Aug. 31, 2023	Aug. 31, 2022
Cash flows from operating activities:
Net income	$ 439,875	$ 600,256
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Equity in income of unconsolidated joint ventures	(9,975)	(19,696)
Distributions of earnings from unconsolidated joint ventures	12,172	10,679
Amortization of debt issuance costs and premiums	2,525	1,884
Depreciation and amortization	26,986	23,861
Deferred income taxes	14,900	21,100
Loss on early extinguishment of debt	0	3,598
Stock-based compensation	23,934	22,944
Inventory impairments and land option contract abandonments	10,207	9,371
Changes in assets and liabilities:
Receivables	(1,581)	(40,530)
Inventories	355,280	(954,231)
Accounts payable, accrued expenses and other liabilities	(100,486)	94,688
Other, net	(1,314)	2,077
Net cash provided by (used in) operating activities	772,523	(223,999)
Cash flows from investing activities:
Contributions to unconsolidated joint ventures	(23,461)	(21,609)
Return of investments in unconsolidated joint ventures	5,100	1,255
Purchases of property and equipment, net	(26,412)	(33,766)
Net cash used in investing activities	(44,773)	(54,120)
Cash flows from financing activities:
Proceeds from issuance of debt	0	350,000
Repayment of senior notes	0	(353,598)
Payment of issuance costs	0	(10,695)
Borrowings under revolving credit facility	170,000	1,485,000
Repayments under revolving credit facility	(320,000)	(1,135,000)
Payments on mortgages and land contracts due to land sellers and other loans	(3,188)	(400)
Issuance of common stock under employee stock plans	8,608	0
Stock repurchases	(249,588)	(100,000)
Tax payments associated with stock-based compensation awards	(9,748)	(12,153)
Payments of cash dividends	(41,635)	(39,914)
Net cash provided by (used in) financing activities	(445,551)	183,240
Net increase (decrease) in cash and cash equivalents	282,199	(94,879)
Cash and cash equivalents at beginning of period	330,198	292,136
Cash and cash equivalents at end of period	$ 612,397	$ 197,257